News
Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...
The maker of Ozempic and Wegovy found fake 1-milligram injections were being distributed through unauthorized sellers.
For decades, the medical approach to treating obesity in children was the wait-and-see approach. But a new Canadian guideline ...
The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...
The Canadian Press on MSN3h
New obesity guidelines for kids address when medication is an optionA new guideline for treating obesity in children and adolescents says medication can be helpful, but that health providers ...
3d
Scripps News on MSNRFK Jr. weighs options for Medicare, Medicaid coverage of GLP-1 medicationsAs discussions unfold, Kennedy seeks to balance drug accessibility with concerns about the long-term costs of providing GLP-1 ...
During a recent finance committee meeting, Deputy Comptroller Delano Dowell confirmed to the Common Council that so far in fiscal year 2024-2025, Buffalo has incumbered $2.1 million of unexpected ...
In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...
A popular weight-loss drug used by celebrities overseas has been approved by New Zealand’s medicine regulatory body, with its producer hoping to make it accessible “as soon as possible”. Wegovy is a ...
The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...
The maker of Ozempic and the weight loss drug Wegovy told the FDA on April 3 that counterfeit 1-milligram injections were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results